--- title: "INTEGRA LIFESCIENCES HOLDINGS CORP (IART) news: class action" url: "https://aibio.space/companies/integra-lifesciences/" publisher: "aibio.space (Biotech Investor Relations News)" summary: "IART class action news: Integra LifeSciences details New Jersey class action and two derivative suits in 10-Q." --- IART INTEGRA LIFESCIENCES HOLDINGS CORP NASDAQ · United States # INTEGRA LIFESCIENCES HOLDINGS CORP (IART) news IART class action news Legal · 2026-10-23 ## [Integra LifeSciences details New Jersey class action and two derivative suits in 10-Q](https://aibio.space/news/integra-lifesciences-details-new-jersey-class-action-two-derivative/) The 2023 Pembroke Pines suit over FDA findings at the Boston plant is still being contested after a supplemental amended complaint. Two derivative suits are stayed behind it. ## Latest INTEGRA LIFESCIENCES HOLDINGS CORP news 1. 2026-10-19 Debt Financing [Integra LifeSciences sells $450 million of 9.500% senior secured notes, refinances credit facility](https://aibio.space/news/integra-lifesciences-sells-450-million-9-500-percent-senior-secured/) Integra refinanced a $1.3 billion revolver and a $775 million term loan with $450 million of 9.500% notes due 2033 and a $1.65 billion credit agreement, after reporting a 2025 net loss of $516.5 million. 2. 2026-10-09 Debt Financing [Integra LifeSciences prices $450,000,000 senior secured notes](https://aibio.space/news/integra-lifesciences-prices-450-000-000-senior-secured-notes/) The 9.500% notes are due 2033 and will help refinance the company's existing credit facilities. 3. 2025-06-09 Debt Financing [Integra LifeSciences amends credit agreement for covenant relief on leverage ratio](https://aibio.space/news/integra-lifesciences-amends-credit-agreement-covenant-relief-leverage/) Integra LifeSciences' June 6, 2025 amendment lifts its maximum consolidated total leverage ratio to 5.00 to 1.00 through June 30, 2026, then steps it down. The company says total indebtedness does not rise, but the amendment also restricts investments, new borrowing and transfers of intellectual property until the relief period ends. ## INTEGRA LIFESCIENCES HOLDINGS CORP at a glance - **Ticker**: IART - **Listing**: NASDAQ - **Country**: United States - **Cash, Sep 30, 2026**: $311.9 million ### Related companies - [Hongchang International Co.](https://aibio.space/companies/hongchang-international/) OTC: HCIL - [Renalytix](https://aibio.space/companies/renalytix/) OTC: RNLXY - [FEMASYS INC](https://aibio.space/companies/femasys/) NASDAQ: FEMY - [LUDWIG ENTERPRISES, INC.](https://aibio.space/companies/ludwig-enterprises/) OTC: LUDG - [TransMedics Group](https://aibio.space/companies/transmedics/) NASDAQ: TMDX - [PMGC Holdings](https://aibio.space/companies/pmgc/) NASDAQ: ELAB - [First Choice Healthcare Solutions](https://aibio.space/companies/first-choice-healthcare-solutions/) OTC: FCHS - [iSpecimen](https://aibio.space/companies/ispecimen/) NASDAQ: ISPC ### Also on NASDAQ - [XBiotech](https://aibio.space/companies/xbiotech/) XBIT - [Mobia Medical](https://aibio.space/companies/mobia-medical/) MOBI - [Dogwood Therapeutics](https://aibio.space/companies/dogwood-therapeutics/) DWTX - [Obsidian Therapeutics](https://aibio.space/companies/obsidian-therapeutics/) OBX - [AN2 Therapeutics](https://aibio.space/companies/an2-therapeutics/) ANTX - [BioNTech](https://aibio.space/companies/biontech/) BNTX ## INTEGRA LIFESCIENCES HOLDINGS CORP annual financials | Line | FY2025 | FY2024 | |---|---|---| | Revenue | [$1.64 billion](https://www.sec.gov/Archives/edgar/data/917520/000091752026000011/) | [$1.61 billion](https://www.sec.gov/Archives/edgar/data/917520/000091752026000011/) | | Net income (loss) | [-$516.5 million](https://www.sec.gov/Archives/edgar/data/917520/000091752026000011/) | [-$6.9 million](https://www.sec.gov/Archives/edgar/data/917520/000091752026000011/) | | Cash from operations | [$50.4 million](https://www.sec.gov/Archives/edgar/data/917520/000091752026000011/) | [$129.4 million](https://www.sec.gov/Archives/edgar/data/917520/000091752026000011/) | | Cash and equivalents | [$235.0 million](https://www.sec.gov/Archives/edgar/data/917520/000091752026000077/) | [$246.4 million](https://www.sec.gov/Archives/edgar/data/917520/000091752026000011/) | | Short-term investments | [$28.7 million](https://www.sec.gov/Archives/edgar/data/917520/000091752026000077/) | [$27.2 million](https://www.sec.gov/Archives/edgar/data/917520/000091752026000011/) | Latest balance sheet, Sep 30, 2026 (10-Q): cash and equivalents $252.3 million, plus short-term investments of $59.7 million, $311.9 million in all. Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice. ## Questions about INTEGRA LIFESCIENCES HOLDINGS CORP Is there a class action against INTEGRA LIFESCIENCES HOLDINGS CORP? Our latest story on this, dated Oct 23, 2026: "Integra LifeSciences details New Jersey class action and two derivative suits in 10-Q". The story links the filing or release it is based on. [Read the story](https://aibio.space/news/integra-lifesciences-details-new-jersey-class-action-two-derivative/). What is the ticker symbol of INTEGRA LIFESCIENCES HOLDINGS CORP? INTEGRA LIFESCIENCES HOLDINGS CORP trades under the ticker IART on NASDAQ. Where is INTEGRA LIFESCIENCES HOLDINGS CORP listed? INTEGRA LIFESCIENCES HOLDINGS CORP is listed on NASDAQ. Which country or territory is INTEGRA LIFESCIENCES HOLDINGS CORP listed under? Our directory records INTEGRA LIFESCIENCES HOLDINGS CORP under United States. Does aibio.space cover INTEGRA LIFESCIENCES HOLDINGS CORP? aibio.space lists INTEGRA LIFESCIENCES HOLDINGS CORP among 2,820 public biotech companies and publishes its news here as stories appear. What was INTEGRA LIFESCIENCES HOLDINGS CORP's revenue last year? $1.64 billion for the fiscal year ended Dec 31, 2025, as reported to the SEC. Is INTEGRA LIFESCIENCES HOLDINGS CORP profitable? INTEGRA LIFESCIENCES HOLDINGS CORP reported a net loss of $516.5 million for the fiscal year ended Dec 31, 2025, and generated $50.4 million of cash from operations, per its annual report to the SEC. How much cash does INTEGRA LIFESCIENCES HOLDINGS CORP have? $311.9 million in cash and short-term investments at Sep 30, 2026, per its 10-Q. What is the latest INTEGRA LIFESCIENCES HOLDINGS CORP (IART) stock news? Our latest story on INTEGRA LIFESCIENCES HOLDINGS CORP, dated Oct 23, 2026: "Integra LifeSciences details New Jersey class action and two derivative suits in 10-Q". The 2023 Pembroke Pines suit over FDA findings at the Boston plant is still being contested after a supplemental amended complaint. Two derivative suits are stayed behind it. [Source](https://aibio.space/news/integra-lifesciences-details-new-jersey-class-action-two-derivative/). Does INTEGRA LIFESCIENCES HOLDINGS CORP have debt, a term loan or convertible notes? Our latest debt story, dated Oct 19, 2026: "Integra LifeSciences sells $450 million of 9.500% senior secured notes, refinances credit facility". Integra refinanced a $1.3 billion revolver and a $775 million term loan with $450 million of 9.500% notes due 2033 and a $1.65 billion credit agreement, after reporting a 2025 net loss of $516.5 million. [Source](https://aibio.space/news/integra-lifesciences-sells-450-million-9-500-percent-senior-secured/). How can I follow INTEGRA LIFESCIENCES HOLDINGS CORP (IART) news? Press Follow on this page to add INTEGRA LIFESCIENCES HOLDINGS CORP to your Following list, or subscribe to the aibio.space newsletter. We have published 4 stories naming INTEGRA LIFESCIENCES HOLDINGS CORP so far, in Debt Financing, Legal. ## Investor discussion: INTEGRA LIFESCIENCES HOLDINGS CORP Members talk about INTEGRA LIFESCIENCES HOLDINGS CORP (IART). Reader posts, not aibio.space reporting, and not investment advice. Rules 1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information. 2. **Say whether you hold the stock.** Every post states long, short or no position. 3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you. 4. **No buy or sell calls and no price targets.** 5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them. 6. **No personal details and no spam.** No links at all for your first 7 days as a member. Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion). ## Stock chart Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open NASDAQ:IART on TradingView](https://www.tradingview.com/symbols/NASDAQ-IART/). ## Listing details INTEGRA LIFESCIENCES HOLDINGS CORP is a public biotech or pharmaceutical company listed on NASDAQ under the ticker IART, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. - **Company**: INTEGRA LIFESCIENCES HOLDINGS CORP - **Ticker**: IART - **Listing**: NASDAQ - **Country or territory**: United States Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/). Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/). Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update) --- Source page: https://aibio.space/companies/integra-lifesciences/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "INTEGRA LIFESCIENCES HOLDINGS CORP (IART) news: class action", 2026-10-31, https://aibio.space/companies/integra-lifesciences/